Breast Neoplasms  >>  epirubicin  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

7 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
epirubicin / Generic mfg.
NCT01110291: Study of Usefulness of Genotyping to Predict Docetaxel Exposure and Adverse Events

Completed
N/A
20
Europe
docetaxel + CEF
University of Turku, Sanofi, Turku University Hospital, Vaasa Central Hospital, Vaasa, Finland, medbase Oy Ltd
CYP3A Phenotyping, CYP3A5 and MDR1 Genotyping, Docetaxel Toxicity, Associations Between Genetic Data and Docetaxel Toxicity
01/04
03/09
NCT00146588: Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer

Completed
N/A
55
US
Cyclophosphamide, Cytoxan, Epirubicin, Capecitabine
Craig A. Bunnell, MD, MPH, Dana-Farber Cancer Institute, Massachusetts General Hospital, Brigham and Women's Hospital, Beth Israel Deaconess Medical Center, Pharmacia
Breast Cancer, Stage I Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
12/04
12/04
NCT00617370: Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: Feasibility

Completed
N/A
38
US
epirubicin, cyclophosphamide, Paclitaxel,
Memorial Sloan Kettering Cancer Center, Amgen, Pfizer
Breast Cancer, Adenocarcinoma of the Breast
07/05
06/08
NCT00131612: An Investigation of the Effect of the Promoter Polymorphism in the Glucuronosyltransferase 2B7 in Patients on Breast Cancer Treatment

Terminated
N/A
120
Canada
FEC 100
AHS Cancer Control Alberta
Breast Cancer
12/05
01/13
NCT01061359: Application Of Epirubicin Within A Neo-/Adjuvant Chemotherapy In Patients With Primary Breast Cancer

Completed
N/A
1981
Europe
Epirubicin: Observational Study
Pfizer
Breast Neoplasm
10/09
10/09
NCT00462696: MRI in Evaluating Early Response to Chemotherapy in Women Receiving Chemotherapy for Infiltrating Breast Cancer

Completed
N/A
30
Europe
docetaxel, epirubicin hydrochloride, conventional surgery, dynamic contrast-enhanced magnetic resonance imaging, neoadjuvant therapy, radiomammography
Institut Bergonié
Breast Cancer
05/11
 
NCT01159236: Molecular Triaging of Newly Diagnosed Breast Cancer

Withdrawn
N/A
0
US
Paclitaxel, Taxol, Fluorouracil, 5-FU, Adrucil, Efudex, Doxorubicin, Rubex, Adriamycin, Epirubicin, Ellence, Cyclophosphamide, Cytoxan, Neosar, Bevacizumab, Avastin, Anti-VEGF monoclonal, rhuMAb-VEGF
M.D. Anderson Cancer Center
Breast Cancer
 
 

Download Options